The loss of NeoGenomics under GAAP for 9 months of 2020 amounted to $11.245 million, against a profit of $1.71 million in the previous year. Revenue increased by 5.5% to $318.451 million, against $301.962 million in the previous year.
The loss of NeoGenomics under GAAP for 9 months of 2020 amounted to $11.245 million, against a profit of $1.71 million in the previous year. Revenue increased by 5.5% to $318.451 million, against $301.962 million in the previous year. 
ir.neogenomics.com
English (US) 